Guardion Health Sciences, Inc. (GHSI) financial statements (2021 and earlier)

Company profile

Business Address 15150 AVENUE OF SCIENCE, SUITE 200
SAN DIEGO, CA 92128
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11150
Cash and cash equivalents11150
Receivables0000
Inventory, net of allowances, customer advances and progress billings0000
Inventory0000
Prepaid expense00  
Other current assets00  
Other undisclosed current assets(0)(0)00
Total current assets:12150
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment0000
Intangible assets, net (including goodwill)022 
Goodwill 22 
Intangible assets, net (excluding goodwill)001 
Deposits noncurrent assets0   
Deferred costs 0  
Other noncurrent assets00  
Other undisclosed noncurrent assets(0) 00
Total noncurrent assets:1320
TOTAL ASSETS:13470
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:0000
Other undisclosed accounts payable and accrued liabilities0000
Debt0 00
Deferred rent credit00
Derivative instruments and hedges, liabilities0   
Due to related parties  00
Deferred revenue and credits00
Other undisclosed current liabilities   0
Total current liabilities:0001
Noncurrent Liabilities
Long-term debt and lease obligation0   
Operating lease, liability0
Total noncurrent liabilities:0   
Total liabilities:1001
Stockholders' equity
Stockholders' equity attributable to parent, including:12370
Preferred stock   0
Common stock0000
Additional paid in capital57383420
Accumulated deficit(46)(35)(27)(21)
Other undisclosed stockholders' equity attributable to parent   1
Other undisclosed stockholders' equity   (1)
Total stockholders' equity:1237(0)
TOTAL LIABILITIES AND EQUITY:13470

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues1100
Revenue, net00
Amortization of lease incentives(0) 
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)(0)(0)
Gross profit:1100
Operating expenses(11)(7)(6)(4)
Operating loss:(10)(6)(5)(4)
Nonoperating income (expense)0(2)  
Interest and debt expense(0)(0)(0)(2)
Net loss:(10)(8)(5)(6)
Other undisclosed net income (loss) attributable to parent(1)0  
Net loss attributable to parent:(11)(8)(5)(6)
Preferred stock dividends and other adjustments  (0)(0)
Other undisclosed net loss available to common stockholders, basic  (1)(1)
Net loss available to common stockholders, diluted:(11)(8)(6)(7)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(10)(8)(5)(6)
Comprehensive loss, net of tax, attributable to parent:(10)(8)(5)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: